Cargando…
Loss of Parkinson’s susceptibility gene LRRK2 promotes carcinogen-induced lung tumorigenesis
Pathological links between neurodegenerative disease and cancer are emerging. LRRK2 overactivity contributes to Parkinson’s disease, whereas our previous analyses of public cancer patient data revealed that decreased LRRK2 expression is associated with lung adenocarcinoma (LUAD). The clinical and fu...
Autores principales: | Lebovitz, Chandra, Wretham, Nicole, Osooly, Maryam, Milne, Katy, Dash, Tia, Thornton, Shelby, Tessier-Cloutier, Basile, Sathiyaseelan, Paalini, Bortnik, Svetlana, Go, Nancy Erro, Halvorsen, Elizabeth, Cederberg, Rachel A., Chow, Norman, Dos Santos, Nancy, Bennewith, Kevin L., Nelson, Brad H., Bally, Marcel B., Lam, Wan L., Gorski, Sharon M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822882/ https://www.ncbi.nlm.nih.gov/pubmed/33483550 http://dx.doi.org/10.1038/s41598-021-81639-0 |
Ejemplares similares
-
Identification of breast cancer cell subtypes sensitive to ATG4B inhibition
por: Bortnik, Svetlana, et al.
Publicado: (2016) -
PEG Conjugated Zein Nanoparticles for In Vivo Use
por: van Ballegooie, Courtney, et al.
Publicado: (2022) -
Expression Analysis of Lrrk1, Lrrk2 and Lrrk2 Splice Variants in Mice
por: Giesert, Florian, et al.
Publicado: (2013) -
Clinical Applications of Autophagy Proteins in Cancer: From Potential Targets to Biomarkers
por: Bortnik, Svetlana, et al.
Publicado: (2017) -
Dynamic and redundant regulation of LRRK2 and LRRK1 expression
por: Biskup, Saskia, et al.
Publicado: (2007)